However, although almost all pancreatic adenocarcinomas have inactivating alterations of this gene, until recently CDKN2A was not considered a PC susceptibility gene outside of the known association with melanoma and the melanoma-PC syndromes. The gene discussed is CDKN2A; the disease is melanoma.